UTRN
Basic information
Region (hg38): 6:144285335-144853034
Previous symbols: [ "DMDL" ]
Links
Phenotypes
GenCC
Source:
- schizophrenia (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UTRN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 14 | 24 | |||
missense | 200 | 14 | 223 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 4 | 3 | 7 | |||
non coding | 61 | 63 | ||||
Total | 0 | 1 | 200 | 26 | 84 |
Variants in UTRN
This is a list of pathogenic ClinVar variants found in the UTRN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-144291533-T-G | Benign (Jun 19, 2021) | |||
6-144291828-G-A | Benign (Jun 09, 2021) | |||
6-144292201-C-T | Benign (Jun 19, 2021) | |||
6-144403123-A-G | not specified | Uncertain significance (Oct 17, 2023) | ||
6-144421902-A-G | not specified | Uncertain significance (May 27, 2022) | ||
6-144421904-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
6-144421909-C-T | not specified | Uncertain significance (Jul 13, 2021) | ||
6-144421951-G-C | not specified | Uncertain significance (Jun 05, 2024) | ||
6-144423571-G-C | not specified | Uncertain significance (May 15, 2024) | ||
6-144423616-A-T | not specified | Uncertain significance (Jun 09, 2022) | ||
6-144423624-A-G | not specified | Uncertain significance (Apr 23, 2024) | ||
6-144424014-A-G | not specified | Uncertain significance (Jul 09, 2021) | ||
6-144424035-A-G | not specified | Uncertain significance (Jun 28, 2022) | ||
6-144424081-G-A | not specified | Likely benign (Feb 16, 2017) | ||
6-144426347-C-G | not specified | Uncertain significance (Aug 31, 2022) | ||
6-144426372-C-G | not specified | Uncertain significance (Jun 24, 2022) | ||
6-144426453-G-A | not specified | Uncertain significance (Jan 18, 2022) | ||
6-144428784-T-A | not specified | Uncertain significance (Nov 21, 2022) | ||
6-144428833-G-A | not specified | Uncertain significance (Mar 04, 2024) | ||
6-144428886-T-C | Benign (Mar 01, 2018) | |||
6-144429589-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
6-144429608-A-T | not specified | Uncertain significance (May 23, 2024) | ||
6-144429676-C-T | not specified | Uncertain significance (May 27, 2022) | ||
6-144429721-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
6-144429737-T-C | not specified | Uncertain significance (Feb 06, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UTRN | protein_coding | protein_coding | ENST00000367545 | 74 | 567334 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00e-19 | 1.00 | 125471 | 2 | 275 | 125748 | 0.00110 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.371 | 1723 | 1.77e+3 | 0.975 | 0.0000951 | 22728 |
Missense in Polyphen | 609 | 736.16 | 0.82726 | 9512 | ||
Synonymous | 0.105 | 642 | 645 | 0.995 | 0.0000356 | 6203 |
Loss of Function | 8.61 | 73 | 206 | 0.354 | 0.0000113 | 2381 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00217 | 0.00215 |
Ashkenazi Jewish | 0.000299 | 0.000298 |
East Asian | 0.00104 | 0.00103 |
Finnish | 0.000881 | 0.000878 |
European (Non-Finnish) | 0.00137 | 0.00133 |
Middle Eastern | 0.00104 | 0.00103 |
South Asian | 0.000402 | 0.000392 |
Other | 0.00180 | 0.00179 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in anchoring the cytoskeleton to the plasma membrane. {ECO:0000250}.;
- Pathway
- Primary Focal Segmental Glomerulosclerosis FSGS;agrin in postsynaptic differentiation
(Consensus)
Recessive Scores
- pRec
- 0.561
Intolerance Scores
- loftool
- 0.595
- rvis_EVS
- -1.55
- rvis_percentile_EVS
- 3.26
Haploinsufficiency Scores
- pHI
- 0.179
- hipred
- Y
- hipred_score
- 0.637
- ghis
- 0.564
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.871
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Utrn
- Phenotype
- growth/size/body region phenotype; muscle phenotype; homeostasis/metabolism phenotype; immune system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype;
Gene ontology
- Biological process
- positive regulation of cell-matrix adhesion;muscle contraction;muscle organ development;neuromuscular junction development;response to denervation involved in regulation of muscle adaptation;regulation of sodium ion transmembrane transporter activity
- Cellular component
- nucleoplasm;cytoplasm;cytoskeleton;plasma membrane;dystrophin-associated glycoprotein complex;membrane;cell junction;filopodium;growth cone;cortical actin cytoskeleton;filopodium membrane;neuromuscular junction;protein-containing complex;sarcolemma;postsynaptic membrane;extracellular exosome;contractile ring
- Molecular function
- actin binding;integrin binding;protein binding;zinc ion binding;vinculin binding;protein kinase binding;actin filament binding